Aoxing Pharmaceutical Company Inc Stock Nyse
Equities
US03740A1060
Pharmaceuticals
Financials (USD)
Sales 2015 | 25.48M | Sales 2016 | 32.33M | Capitalization | 49.54M |
---|---|---|---|---|---|
Net income 2015 | 5M | Net income 2016 | 2M | EV / Sales 2015 | 5.77 x |
Net Debt 2015 | 24.8M | Net Debt 2016 | 18.56M | EV / Sales 2016 | 2.11 x |
P/E ratio 2015 |
20.1
x | P/E ratio 2016 |
23.2
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 23-08-10 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 10-12-31 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 23-08-10 |
1st Jan change | Capi. | |
---|---|---|
+22.35% | 44.12B | |
+22.22% | 22.61B | |
+17.66% | 15.11B | |
+15.73% | 13.61B | |
+57.91% | 13.34B | |
-8.98% | 6.94B | |
-0.05% | 6.79B | |
+15.65% | 5.75B | |
-8.87% | 5.73B |